Terumo Corporation

Terumo Corporation

Financial Results for the First Quarter of Fiscal Year Ending March 31, 2020 (FY2019)

August 8, 2019

Executive Officer
Chief Accounting and Financial Officer (CAFO)
Naoki Muto

PLAY LIST

from the beginning

Financial Results for the First Quarter of Fiscal Year Ending March 31, 2020 (FY2019)
  • Profit Above the Guidance with Double Digit Growth
  • Adjusted Operating Profit Variance Analysis
  • Revenue by Region
  • Revenue by Business Segment
  • Cardiac and Vascular : Double Digit Growth in Revenue and Profit
  • General Hospital : A Start Largely in Line with the Guidance
  • Blood Management : Revenue Slightly Behind the Plan,Profit as Planned
  • Major Topics in FY19 Q1
  • New Products Pipeline in FY19
  • Enhances Coronary Interventional Product Portfolio
Reference
  • FY19 Q1 Revenue and Growth by Region
  • Operating Expenses
  • Quarterly Results
  • Adjusted Operating Profit : Adjustments
  • CAPEX and R&D Expenses
  • Cash Flows
  • Foreign Exchange Sensitivity
  • The Status of Convertible Bonds
  • IR Contact
  • Back
  • Next

Download

  • Presentation Material "Financial Results for the First Quarter of FYE 3/2020"(PDF 601 KB)
  • Financial Statements "Financial Results for the First Quarter of FYE 3/2020"(PDF 478 KB)
  • Questionnaire Please answer the questionnair
  • Forward-Looking Statements
    System Requirements
GreenPower
link corporate communications